Navigation Links
Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient
Date:10/26/2009

PHILADELPHIA, Oct. 26 /PRNewswire/ -- Pleio Health Support Systems, Inc. (Pleio) announces updated results of the Pleio GoodStart(TM) medication adherence program. Retrospective analysis of retail pharmacy prescription data from 1,776 patients taking a chronic cardiovascular medication between May 2008 and September 2009, revealed that Pleio GoodStart(TM) had a highly significant impact on medication adherence, resulting in patients refilling an average of two additional 30-day prescriptions during their initial 9-month period on the medication (p<0.001).

Data also showed that patients who participated in the GoodStart(TM) program refilled their prescriptions an average of ten days sooner than control group participants. Collectively, these data demonstrate a significant, sustained improvement in patient medication adherence with the Pleio GoodStart(TM) program.

"Improving people's experience with new prescription medications involves many disciplines. Pleio's technology, pharmacy and manufacturer partners are equally dedicated to improving the patient experience with new prescriptions. These results show that when elderly patients are carefully listened to, stimulated in language they can relate to, and empowered with performance support, adherence challenges are easily overcome."

Pleio GoodStart connects physicians, patients, pharmacies, families and pharmaceutical manufacturers toward their common goal of improved patient adherence. Physicians gain the assurance that their patients will be well-supported and that future patient appointments can be more effective. Pharmacies are provided a new perspective on C&P through training and feedback on patient progress. Patients receive unprecedented interest in their welfare throughout the medication adoption phase, with up to 75 contacts during their first 100 days on therapy. Family and friend support is stimulated through awareness of the issue of adherence and thei
'/>"/>

SOURCE Pleio Health Support Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
2. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
3. Patients Receiving High Radiation at Cedars Sinai File Class Action Lawsuit
4. Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
5. Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers
6. ULORIC(R) (febuxostat) Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout
7. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
8. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
9. New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone
10. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
11. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... Auf seiner am ... veranstalteten F&E-Tagung meldete Astellas Fortschritte im ... Forschungsrahmenprogramms. Die Tagung bot Astellas die Gelegenheit, ... Programme und die Konzernstrategie des Unternehmens zu ... aktuelle Meldungen zu den Astellas-Initiativen in den ...
(Date:7/13/2014)... , July 13, 2014  Eli Lilly ... announced results from its non-clinical study in genetically ... version of the beta-amyloid antibody N3pG and beta-secretase ... therapy was more effective in removing clumps of ... that is thought to lead to Alzheimer,s disease ...
(Date:7/11/2014)... , July 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. ... vegetable-glycol solution for use in portable vaporizers, which ... active ingredients in cannabis, cannabidiol offers consumers a ... devices, and other vaporizer technology. Photo ... naturally contains 483 different compounds which are currently ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
... is,being released by The Philadelphia AIDS Consortium:, ... with its network of eleven (11) community-based organization,sites ... of 30 AmeriCorps ACTS members working throughout New,Jersey, ... 2008: 9 a.m. until Noon; Media Focused,Event 10:30 ...
... highlights:, In a small study, miniaturized heart pumps ... The devices are not approved for general use ... In a recent study, nine,pediatric patients with severe heart ... days with miniaturized heart assist pumps while,awaiting a heart ...
Cached Medicine Technology:Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures 2American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant 2
(Date:7/13/2014)... (PRWEB) July 13, 2014 MarketsandMarkets ... Market [3D Modeling; 3D Scanning; 3D rendering; Layout ... and Analysis (2013 - 2018)”, which analyzes and ... in North America, Western Europe, Eastern Europe, Middle ... report also draws the competitive landscape of the ...
(Date:7/13/2014)... Seattle, WA (PRWEB) July 13, 2014 ... a longer recovery period from concussions, according to research ... Medicine’s ( AOSSM ) Annual Meeting. The research marks ... to concussion based on the known physical events that ... that patients with a long allele in the (GT)n ...
(Date:7/13/2014)... July 13, 2014 Recently, MyDressCity.com, one ... women’s special occasion outfits, has released its new range ... the new products are available at discounted prices. Worldwide ... 2014. , In the company’s online shop, there ... of them are made with great materials. MyDressCity.com’s hot ...
(Date:7/13/2014)... decreased ability to identify odors might indicate the ... examinations of the eye could indicate the build-up ... the brain, according to the results of four ... International Conference 2014 (AAIC 2014) in Copenhagen. , ... to identify odors was significantly associated with loss ...
(Date:7/13/2014)... Celebrity fitness trainer and former World Super ... with Aqua Health Labs for their flagship product PhytOriginal, ... The collaboration was recently announced live on ESPN Radio. ... actor, model, and a two time World Super Middleweight ... has prepared stars including Demi Moore, Hilary Swank and ...
Breaking Medicine News(10 mins):Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2
... Residents to Also Press For ... Immediate ... National House Call campaign visits New Mexico,today and urges residents to ... will slash physician payments 15,percent over the next two years. ...
... F. Murphy Appointed Director, First Ray and Stephanie ... Mellon University,announced today that it has received a ... establish the Ray and Stephanie Lane Center for,Computational ... and provide,support for doctoral and post-doctoral training in ...
... by German scientists may make blood doping and the ... hair. In the October print issue of The FASEB ... 100,000 hair follicles on each persons head have the ... primarily responsible for the creation of red blood cells, ...
... Position as the Global Leader in Endoscopic ... NDO Surgical, Inc. (NDO),announced that the ... the,Company,s Plicator II(TM) multiple implant technology for ... improved outcomes for,harder-to-treat gastroesophageal reflux disease (GERD) ...
... research that aligns patients and treatments., ... The,H. Lee Moffitt Cancer Center & ... health enterprise platform, to aid in its,development ... be used,to assimilate large quantities of diverse ...
... of Michigan has,received a national award for leadership excellence ... BCN received a DMAA Disease Management Leadership Award ... for Healthy Blue Living(SM),the innovative product BCN introduced in ... attempting to meet healthy lifestyle goals. "It is ...
Cached Medicine News:Health News:AMA Urges Congress to Stop Medicare Cuts 2Health News:Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology 2Health News:Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology 3Health News: New discovery leaves blood-doping athletes scratching their heads 2Health News:NDO Receives FDA 510(K) Clearance for Plicator II(TM) 2Health News:Moffitt Selects Microsoft's Azyxxi to Help Drive Personalized Cancer Treatment 2Health News:Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management 2
Smooth pointed tips open to 3.0 mm. Cross action curved shafts. Tip to Angle Length: 12.0 mm. Round handle....
Straight, narrowed shafts with extra fine blunted tips. Smooth handle with dull finish....
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model....
Fine pointed grooved jaws with smooth curve from tip to finger grip style handle. Dull finish....
Medicine Products: